DBV Technologies S.A. SEC filings DBVTF
DBV Technologies S.A. has 576 filings in SEC EDGAR's recent list, going back to Jul 25, 2014. Its latest annual report, Form ARS, was filed on May 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 28, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3ASR | Automatic shelf registration | Jul 27, 2026 | — |
| S-8 | Employee stock plan registration | Jun 4, 2026 | — |
| S-8 | Employee stock plan registration | May 4, 2026 | — |
| 424B5 | Prospectus supplement | Sep 5, 2025 | — |
| S-8 | Employee stock plan registration | Jun 24, 2025 | — |
| 424B3 | Prospectus | May 29, 2025 | — |
| S-3 | Shelf registration | May 19, 2025 | — |
| F-6 POS | Filing | Nov 12, 2024 | — |
| S-8 | Employee stock plan registration | Jul 2, 2024 | — |
| F-6 POS | Filing | May 17, 2024 | — |
| S-8 | Employee stock plan registration | Nov 20, 2023 | — |
| S-3 | Shelf registration | Apr 6, 2023 | — |
| 424B3 | Prospectus | Aug 11, 2022 | — |
| 424B3 | Prospectus | Aug 11, 2022 | — |
| S-3 | Shelf registration | Aug 1, 2022 | — |
| S-3 | Shelf registration | Aug 1, 2022 | — |
| F-6EF | Filing | Jul 18, 2022 | — |
| F-6EF | Filing | May 25, 2022 | — |
| 424B5 | Prospectus supplement | May 2, 2022 | — |
| S-3 | Shelf registration | Jun 30, 2021 | — |
| F-3ASR | Filing | Apr 30, 2020 | — |
| 424B5 | Prospectus supplement | Jan 30, 2020 | — |
| F-3MEF | Filing | Jan 29, 2020 | — |
| FWP | Free writing prospectus | Jan 29, 2020 | — |
| 424B5 | Prospectus supplement | Jan 29, 2020 | — |
| 424B5 | Prospectus supplement | Oct 9, 2019 | — |
| FWP | Free writing prospectus | Oct 9, 2019 | — |
| 424B5 | Prospectus supplement | Oct 9, 2019 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 6, 2019 | — |
| 424B5 | Prospectus supplement | Apr 4, 2019 | — |
| 424B5 | Prospectus supplement | Apr 3, 2019 | — |
| POS AM | Filing | Apr 1, 2019 | — |
| 424B3 | Prospectus | Oct 15, 2018 | — |
| 424B5 | Prospectus supplement | Mar 21, 2018 | — |
| 424B5 | Prospectus supplement | Mar 20, 2018 | — |
| F-3ASR | Filing | Jul 27, 2016 | — |
| 424B4 | Prospectus | Jul 15, 2015 | — |
| F-1MEF | Filing | Jul 14, 2015 | — |
| F-1/A | Filing | Jul 14, 2015 | — |
| F-1/A | Filing | Jul 6, 2015 | — |
| F-1 | Registration statement (foreign issuer) | Jul 2, 2015 | — |
| S-8 | Employee stock plan registration | Oct 22, 2014 | — |
| 424B4 | Prospectus | Oct 22, 2014 | — |
| F-1/A | Filing | Oct 21, 2014 | — |
| F-1/A | Filing | Oct 15, 2014 | — |
| F-6 | Form f-6 | Oct 9, 2014 | — |
| F-1 | Registration statement (foreign issuer) | Sep 22, 2014 | — |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- DBVT (Nasdaq), DBVTF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- France
- Headquarters
- Chatillon
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1613780
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.